Analysis of mural cell recruitment to tumor vessels

被引:139
作者
Abramsson, A
Berlin, Ö
Papayan, H
Paulin, D
Shani, M
Betsholtz, C
机构
[1] Sahlgrenska Hosp, Dept Orthoped, Gothenburg, Sweden
[2] Univ Denis Diderot Paris 7, Lab Biol Mol Differenciat, Paris, France
[3] Volcani Ctr, Inst Anim Sci, Bet Dagan, Israel
关键词
angiogenesis; cells; pericytes; muscle; smooth; growth substances;
D O I
10.1161/hc0102.101437
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Tumor blood vessels are both structurally and functionally abnormal compared with normal vessels. A limited support of mural cells may contribute to these abnormalities. Here, we characterized mural cell recruitment in 2 mouse tumor models and addressed the question of why tumor vessels fail to recruit a proper coat of mural cells. Methods and Results-We studied mural cell recruitment to the vasculature of 2 transplantable mouse tumor models, T241 fibrosarcoma and KRIB osteosarcoma. We found that both tumors formed a vessel network with heterogeneous and L highly abnormal organization of mural cells. Transplantation of tumors to mice expressing lacZ in mural cells demonstrated that these cells were host-derived. Although tumor vessel endothelium expressed PDGF-B, an embryonic nitrogen for mural cells, only very few PDGFRbeta-positive cells were found to be associated with the developing tumor vasculature, suggesting a limited pool of recruitable mural cells. We tested whether exogenous mural cells could be recruited to tumor vessels by injecting mixtures of T241 tumor cells and embryonic mesenchymal cells isolated from mice expressing lacZ in mural cells. In the tumors that arose, lacZ-positive cells were efficiently recruited to the tumor vessels. Conclusions-T241 and KRIB tumors show a similar highly abnormal organization of vessel-associated mural cells. T241 tumor vessels seem highly capable of recruiting exogenously added mural cells. The sparse mural cell coat of tumor vessels may result from a limited pool of mural cells available for recruitment.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 33 条
[1]  
[Anonymous], 1994, MANIPULATING MOUSE E
[2]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[3]  
Benjamin LE, 1998, DEVELOPMENT, V125, P1591
[4]   VEGF gene therapy: stimulating angiogenesis or angioma-genesis? [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (10) :1102-1103
[5]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[6]   DOMINANT-NEGATIVE AND TARGETED NULL MUTATIONS IN THE ENDOTHELIAL RECEPTOR TYROSINE KINASE, TEK, REVEAL A CRITICAL ROLE IN VASCULOGENESIS OF THE EMBRYO [J].
DUMONT, DJ ;
GRADWOHL, G ;
FONG, GH ;
PURI, MC ;
GERTSENSTEIN, M ;
AUERBACH, A ;
BREITMAN, ML .
GENES & DEVELOPMENT, 1994, 8 (16) :1897-1909
[7]  
Eberhard A, 2000, CANCER RES, V60, P1388
[8]   Clinical applications of angiogenic growth factors and their inhibitors [J].
Ferrara, N ;
Alitalo, K .
NATURE MEDICINE, 1999, 5 (12) :1359-1364
[9]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[10]   Openings between defective endothelial cells explain tumor vessel leakiness [J].
Hashizume, H ;
Baluk, P ;
Morikawa, S ;
McLean, JW ;
Thurston, G ;
Roberge, S ;
Jain, RK ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1363-1380